Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05196074

Airway Closure During Extracorporeal Membrane Oxygenation: The AiCLOSE Study

Status
Recruiting
Phase
Study type
Observational
Enrollment
299 (estimated)
Sponsor
Lorenzo delSorbo · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

About 65,000 Canadians develop acute respiratory failure requiring breathing machines (ventilators) to give oxygen to their lungs. Unfortunately, up to 50% of these individuals will not survive their illness. Mechanical ventilation through breathing machines, though potentially lifesaving, may further injure the lungs and the respiratory muscles. In the patients with the most severe and life threatening forms of respiratory failure a breathing machine alone may not be able to provide enough oxygen to the lungs and vital organs. In these critical situations, patients may require an artificial lung machine, which is referred to as extracorporeal membrane oxygenation (ECMO) to temporarily replace the function of the patient's own lung and supply critical oxygen to the body, while protecting the damaged lungs. How to use the breathing machine safely while a patient is on ECMO is still unknown. Using conventional breathing machine settings while on ECMO can lead to large portions of the lungs or airway to remain collapsed, which can contribute to further lung damage. The investigators have recently discovered a way of detecting if patients on a breathing machine suffer from collapsed airways. Knowing if the most severe patients on ECMO have airway collapse is a pivotal question that the investigators plan to answer in our study. The investigators will use our technique to determine how many patients on ECMO have airway closure and determine if this contributes to a longer time on ECMO and a longer time on a breathing machine, and if this impacts a patient's survival in the intensive care unit.

Conditions

Interventions

TypeNameDescription
OTHERAcute hypoxemic respiratory failure patients on VV-ECMOTo describe the prevalence of complete airway closure in patients with acute hypoxemic respiratory failure on VV-ECMO and its association with outcome.

Timeline

Start date
2022-04-04
Primary completion
2025-04-01
Completion
2026-04-01
First posted
2022-01-19
Last updated
2024-05-10

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT05196074. Inclusion in this directory is not an endorsement.